Relief Therapeutics Holding (XSWX:RLF) Long-Term Debt : CHF0.01 Mil (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Relief Therapeutics Holding Long-Term Debt?

Relief Therapeutics Holding's Long-Term Debt for the quarter that ended in Dec. 2023 was CHF0.01 Mil.

Relief Therapeutics Holding's quarterly Long-Term Debt declined from Dec. 2022 (CHF0.02 Mil) to Jun. 2023 (CHF0.01 Mil) and declined from Jun. 2023 (CHF0.01 Mil) to Dec. 2023 (CHF0.01 Mil).

Relief Therapeutics Holding's annual Long-Term Debt declined from Dec. 2021 (CHF0.40 Mil) to Dec. 2022 (CHF0.02 Mil) and declined from Dec. 2022 (CHF0.02 Mil) to Dec. 2023 (CHF0.01 Mil).

Relief Therapeutics Holding Long-Term Debt Historical Data

The historical data trend for Relief Therapeutics Holding's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Relief Therapeutics Holding Long-Term Debt Chart

Relief Therapeutics Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

0.40

0.02

0.01

Relief Therapeutics Holding Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															0.40	0.39	0.02	0.01	0.01

Relief Therapeutics Holding (XSWX:RLF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Relief Therapeutics Holding Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Relief Therapeutics Holding's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Relief Therapeutics Holding (XSWX:RLF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Relief Therapeutics Holding SA (XSWX:RLF) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

RLFTY:USA RLFTF:USA RLFz:UK

Address

Avenue de Secheron 15, Fondation EIP, Batiment, Geneva, CHE, CH-1202

Website

https://www.relieftherapeutics.com

Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.

Relief Therapeutics Holding (XSWX:RLF) Headlines

No Headlines